These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 27121963

  • 1. Construction and analysis of protein-protein interaction networks based on proteomics data of prostate cancer.
    Chen C, Shen H, Zhang LG, Liu J, Cao XG, Yao AL, Kang SS, Gao WX, Han H, Cao FH, Li ZG.
    Int J Mol Med; 2016 Jun; 37(6):1576-86. PubMed ID: 27121963
    [Abstract] [Full Text] [Related]

  • 2. Protein expression information of prostate infection based on data mining.
    Abula A, Shao W, Tusong H, Wang F, Yasheng A, Wang Y, Wang Y.
    J Infect Public Health; 2020 Oct; 13(10):1533-1536. PubMed ID: 31422041
    [Abstract] [Full Text] [Related]

  • 3. Integrative analysis of ocular complications in atherosclerosis unveils pathway convergence and crosstalk.
    Gupta A, Mohanty P, Bhatnagar S.
    J Recept Signal Transduct Res; 2015 Apr; 35(2):149-64. PubMed ID: 25055025
    [Abstract] [Full Text] [Related]

  • 4. Identification of hub subnetwork based on topological features of genes in breast cancer.
    Zhuang DY, Jiang L, He QQ, Zhou P, Yue T.
    Int J Mol Med; 2015 Mar; 35(3):664-74. PubMed ID: 25573623
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer.
    Davalieva K, Kostovska IM, Kiprijanovska S, Markoska K, Kubelka-Sabit K, Filipovski V, Stavridis S, Stankov O, Komina S, Petrusevska G, Polenakovic M.
    Prostate; 2015 Oct; 75(14):1586-600. PubMed ID: 26074449
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
    Bouali S, Chrétien AS, Ramacci C, Rouyer M, Becuwe P, Merlin JL.
    Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633
    [Abstract] [Full Text] [Related]

  • 10. Comprehensive data mining reveals RTK/RAS signaling pathway as a promoter of prostate cancer lineage plasticity through transcription factors and CNV.
    Wei G, Zhang X, Liu S, Hou W, Dai Z.
    Sci Rep; 2024 May 22; 14(1):11688. PubMed ID: 38778150
    [Abstract] [Full Text] [Related]

  • 11. The prostate cancer immunome: In silico functional analysis of antigenic proteins from microarray profiling with IgG.
    Luna-Coronell JA, Vierlinger K, Gamperl M, Hofbauer J, Berger I, Weinhäusel A.
    Proteomics; 2016 Apr 22; 16(8):1204-14. PubMed ID: 27089054
    [Abstract] [Full Text] [Related]

  • 12. Identification of human prolactinoma related genes by DNA microarray.
    Zhao L, Lin M, Wang S.
    J Cancer Res Ther; 2014 Apr 22; 10(3):544-8. PubMed ID: 25313736
    [Abstract] [Full Text] [Related]

  • 13. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
    Ummanni R, Junker H, Zimmermann U, Venz S, Teller S, Giebel J, Scharf C, Woenckhaus C, Dombrowski F, Walther R.
    Cancer Lett; 2008 Aug 08; 266(2):171-85. PubMed ID: 18384941
    [Abstract] [Full Text] [Related]

  • 14. Identification of key regulators in prostate cancer from gene expression datasets of patients.
    Mangangcha IR, Malik MZ, Küçük Ö, Ali S, Singh RKB.
    Sci Rep; 2019 Nov 11; 9(1):16420. PubMed ID: 31712650
    [Abstract] [Full Text] [Related]

  • 15. Mining featured biomarkers associated with prostatic carcinoma based on bioinformatics.
    Piao G, Wu J.
    Biomarkers; 2013 Nov 11; 18(7):580-6. PubMed ID: 23957850
    [Abstract] [Full Text] [Related]

  • 16. Proteomic analysis of zoledronic-acid resistant prostate cancer cells unveils novel pathways characterizing an invasive phenotype.
    Milone MR, Pucci B, Bifulco K, Iannelli F, Lombardi R, Ciardiello C, Bruzzese F, Carriero MV, Budillon A.
    Oncotarget; 2015 Mar 10; 6(7):5324-41. PubMed ID: 25481874
    [Abstract] [Full Text] [Related]

  • 17. Label-free quantitative phosphoproteomic analysis reveals differentially regulated proteins and pathway in PRRSV-infected pulmonary alveolar macrophages.
    Luo R, Fang L, Jin H, Wang D, An K, Xu N, Chen H, Xiao S.
    J Proteome Res; 2014 Mar 07; 13(3):1270-80. PubMed ID: 24533505
    [Abstract] [Full Text] [Related]

  • 18. Signaling pathway networks mined from human pituitary adenoma proteomics data.
    Zhan X, Desiderio DM.
    BMC Med Genomics; 2010 Apr 28; 3():13. PubMed ID: 20426862
    [Abstract] [Full Text] [Related]

  • 19. Variant analysis of prostate cancer in Japanese patients and a new attempt to predict related biological pathways.
    Kasajima R, Yamaguchi R, Shimizu E, Tamada Y, Niida A, Tremmel G, Kishida T, Aoki I, Imoto S, Miyano S, Uemura H, Miyagi Y.
    Oncol Rep; 2020 Mar 28; 43(3):943-952. PubMed ID: 32020225
    [Abstract] [Full Text] [Related]

  • 20. An integrative proteomics and interaction network-based classifier for prostate cancer diagnosis.
    Jiang FN, He HC, Zhang YQ, Yang DL, Huang JH, Zhu YX, Mo RJ, Chen G, Yang SB, Chen YR, Zhong WD, Zhou WL.
    PLoS One; 2013 Mar 28; 8(5):e63941. PubMed ID: 23737958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.